Back to HomeBeta

ICD-10 Coding for Maculopapular Rash(R21, L51.9, B09)

Complete ICD-10-CM coding and documentation guide for Maculopapular Rash. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Morbilliform RashErythematous Rash

Related ICD-10 Code Ranges

Complete code families applicable to Maculopapular Rash

R20-R23Primary Range

Symptoms and signs involving the skin and subcutaneous tissue

This range includes codes for various skin symptoms, including nonspecific rashes like maculopapular rash.

Urticaria and erythema

This range covers erythematous conditions, including drug-induced rashes.

Viral infections characterized by skin and mucous membrane lesions

This range includes viral exanthems that may present with maculopapular rashes.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
R21Rash and other nonspecific skin eruptionUse when the rash is idiopathic and no specific cause is identified.
  • No identified specific cause
  • Negative drug history
  • No lab confirmation of infection
L51.9Erythema, unspecifiedUse when rash is suspected to be drug-induced.
  • Temporal relationship to medication
  • Resolution after discontinuation of the drug
B09Viral exanthem, unspecifiedUse when rash is associated with a confirmed viral infection.
  • Positive PCR or serology for viral infection
  • Presence of fever and prodrome

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for maculopapular rash

Essential facts and insights about Maculopapular Rash

The ICD-10 code for a nonspecific maculopapular rash is R21. For drug-induced rashes, use L51.9 with appropriate drug codes.

Primary ICD-10-CM Codes for maculopapular rash

Rash and other nonspecific skin eruption
Billable Code

Decision Criteria

clinical Criteria

  • No specific cause identified for the rash.

coding Criteria

  • No lab confirmation of infection or drug involvement.

Applicable To

  • Nonspecific rash
  • Idiopathic rash

Excludes

Clinical Validation Requirements

  • No identified specific cause
  • Negative drug history
  • No lab confirmation of infection

Code-Specific Risks

  • Risk of undercoding if specific etiology is identified later.

Coding Notes

  • Ensure exclusion of specific etiologies before using R21.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances

T36-T50
Use to specify the drug responsible for a drug-induced rash.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Erythema, unspecified

L51.9
Use when rash is drug-induced with a clear temporal relationship to medication.

Viral exanthem, unspecified

B09
Use when rash is associated with viral infection confirmed by lab tests.

Rash and other nonspecific skin eruption

R21
Use R21 if no drug involvement is suspected.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Maculopapular Rash to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code R21.

Impact

Clinical: Inaccurate diagnosis and treatment., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.

Mitigation Strategy

Always document drug history and temporal relationship., Use templates to ensure completeness.

Impact

Reimbursement: Incorrect coding may lead to claim denials., Compliance: Failure to comply with coding guidelines., Data Quality: Inaccurate clinical data representation.

Mitigation Strategy

Use L51.9 with appropriate drug codes (T36-T50) for drug-induced rashes.

Impact

Incorrect coding of drug-induced rashes as nonspecific rashes.

Mitigation Strategy

Use L51.9 with appropriate drug codes and document clearly.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Maculopapular Rash, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Maculopapular Rash

Use these documentation templates to ensure complete and accurate documentation for Maculopapular Rash. These templates include all required elements for proper coding and billing.

Drug-induced maculopapular rash

Specialty: Dermatology

Required Elements

  • Onset and duration
  • Drug history
  • Morphology and distribution
  • Resolution upon drug discontinuation

Example Documentation

Patient presents with a maculopapular rash 3 days after starting amoxicillin. Rash resolved after discontinuation.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Patient has a rash.
Good Documentation Example
Patient developed a maculopapular rash 3 days after starting amoxicillin, resolved after discontinuation.
Explanation
The good example provides specific details about onset, drug involvement, and resolution.

Need help with ICD-10 coding for Maculopapular Rash? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more